Clinical Trial

A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 10, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to substantiate the effectiveness and safety of USPlus® DERM for self-perceived thinning hair compared to placebo in healthy men and women ages 25-65 over the course of six months of continued use. Participants will be asked to have attend three office visits, one phone call, have photos taken of their hair and answer questionnaires related to their thinning hair.
Trial Details
NCT Number NCT06920758
Lead Sponsor Ablon Skin Institute Research Center
Collaborators: U.S. Nutraceuticals, Inc. dba Valensa International
Conditions Thinning Hair
Enrollment 60 participants
Start Date 2024-12-16
Primary Completion 2025-09 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-04-10